Biotech Week articles from September 2002

Biotech Week archives from September 2002

Positive phase I results for RLT Peptide (ETC-642) released.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Esperion Therapeutics, Inc., (ESPR), a biopharmaceutical company focused on discovering and developing HDL-targeted therapies, announced initial positive results from a phase I clinical trial of the...

Protein Design Labs begins phase I clinical trial of Nuvion in ulcerative colitis.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Protein Design Labs, Inc., (PDLI) announced that it has initiated a phase I clinical trial to evaluate the safety and tolerability of its humanized antibody Nuvion (visilizumab) in patients with...

Positive European opinion announced for OvaRex as orphan drug.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- AltaRex Corp. announced that the Committee for Orphan Medical Products (COMP) of the European Agency for the Evaluation of Medicinal Products (EMEA) has adopted a positive opinion recommending the...

Positive preclinical data on JNK inhibitors released.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Celgene Corporation (CELG) scientists, in association with collaborators at the National Heart and Lung Institute of Imperial College of Medicine in London, presented preclinical data at the World...

New joint venture focuses on molecular biology.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- ComGenex, Inc., (Budapest, Hungary), an integrated discovery chemistry provider, who this year celebrates its 10th anniversary, announced an extension of its chemical genomics/proteomics capabilities by...

R&D alliance inked with Pennsylvania State University.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- DNAPrint genomics, Inc., (DNAP) announced that it has entered into a multifaceted alliance with the Pennsylvania State University (PSU) to research and commercialize new genomics-based products for...

Parenteral cephalosporin enters phase I clinical trials.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Essential Therapeutics, Inc., (ETRX) announced that its partner, Johnson & Johnson Pharmaceutical Research & Development, LLC, (J&JPRD) has recently initiated phase I clinical trials with a prodrug...

Advances in research will improve treatment of urological disorders.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- As the baby boom generation continues to age, scientists are pursuing medical advances that may someday lead to treating a variety of health conditions that are expected to impact this ever-growing...

AGY Therapeutics raises $31.3M and appoints two new board members.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- AGY Therapeutics, Inc., a privately held biopharmaceutical company, announced that the company raised $31.3 million through a Series C financing round, which was led by Bear Stearns Health Innoventures...

Growth in sales, earnings per share reported.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories reported increases in both sales and earnings for the second quarter and the first half ended June 30, 2002, excluding one-time charges. Worldwide sales for the second quarter were...

GeneChip EasyAccess silver agreement inked with Immunex.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Affymetrix, Inc., (AFFX) announced that it has entered into an EasyAccess Silver agreement with Seattle-based Immunex Corporation (IMNX). Under the agreement, Immunex will gain broad access to...

Proprietary ribonuclease-based product pipeline expanded.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Alfacell Corporation (ACEL) announced the discovery of four new, novel enzymes that were reported at the 6th International Conference on Ribonucleases held in Bath, England. This conference was...

FDA approves tizanidine hydrochloride.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Alpharma, Inc., announced that Purepac Pharmaceutical Co., a subsidiary of Alpharma, has received approval from the United States Food and Drug Administration (FDA) to manufacture and market tizanidine...

Research partnership agreement unveiled.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- In the latest of a series of new business development deals, life sciences discovery pioneer AnVil and leading clinical research network Owl Research Group, announced a wide-ranging partnership that...

Structural GenomiX announces drug discovery partnership with Japanese company.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Privately held Structural GenomiX, Inc., (SGX) and Asahi Kasei Corp. of Japan announced a collaboration agreement to utilize SGX's structure guided drug discovery technologies to identify lead compounds...

G. John Mohr named as vice president of business development.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- AtheroGenics, Inc., (AGIX), a pharmaceutical company focused on the discovery, development, and commercialization of novel drugs for the treatment of chronic inflammatory diseases, announced the...

Partial settlement reached in Cardizem antitrust case.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Aventis announced that it has reached a preliminary partial settlement agreement in the Cardizem CD (diltiazem HCl) antitrust multidistrict litigation. The settlement pertains to claims brought by a...

Agreement signed with ArQule.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- BSI Proteomics Corp. (BSI), a privately owned protein structure solution company, announced that it has signed a services agreement with ArQule, Inc., (ARQL), a drug discovery company. Under the...

Company streamlines operations.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- BioCryst Pharmaceuticals, Inc., (BCRX) announced that in order to conserve its resources, it has reduced its staff by 30, bringing the total number of BioCryst employees to 45. BioCryst had...

Public offering completed.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- BioDelivery Sciences International, Inc., (BDSIU) announced the completion, on June 28th, 2002, of its public offering of 2,000,000 units priced at $5.25 per unit for total proceeds to the company,...

New CFO, board members named.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- BioMarin Pharmaceutical, Inc., (BMRN) announced that it has appointed a new chief financial officer and elected three new members to its board of directors. On August 1, 2002, Louis Drapeau joined...

Christine Carberry named vice president, program, alliance management.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Biogen, Inc., (BGEN) announced that Christine Carberry has been appointed vice president, program and alliance management. Carberry will oversee Biogen's development programs in the areas of...

Second quarter sales increase 65%.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Biolase Technology, Inc., (BLTI), a medical technology company focused on pain-free medical and dental procedures, reported that second quarter sales reached a record $7.2 million from $4.3 million in...

Companies sign gene therapy research, option agreement.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Boehringer Ingelheim and Genetronics Biomedical Corporation (GEB) Toronto signed a Research and Option Agreement to evaluate the performance of Genetronics' electroporation technology for the delivery...

Acquisition of BEI Medical Systems complete.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Boston Scientific Corporation (BSX) announced the completion of the acquisition of BEI Medical Systems Company, Inc., by Boston Scientific for approximately $95 million in an all-cash transaction. ...

Equity position in Natural Pharmaceuticals increased.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Boston Scientific Corporation (BSX) announced it has increased its equity position in Natural Pharmaceuticals, Inc., (NPI) by acquiring additional shares of the company. In addition, NPI has...

2Q earnings per share up approximately 133% from 2001.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Bradley Pharmaceuticals, Inc., (BPRX) announced second quarter financial results will meet or exceed previously announced expectations. Estimated net sales for the second quarter 2002, ended June...

Company responds to SEC regarding wholesaler inventory issue.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Bristol-Myers Squibb (BMY) has been in communication with the U.S. Securities and Exchange Commission (SEC) since April 2002 regarding its domestic wholesaler inventories. News reports indicated...

Collaboration to focus on cancer biology research.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Cellomics, Inc., announced that they have signed a collaborative agreement with the University of California, San Francisco (UCSF) Comprehensive Cancer Center. UCSF will implement Cellomics' High...

Second quarter 2002 sales up 82%.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Cepheid (CPHD), developer and marketer of real-time DNA detection systems, announced financial results for the quarter and 6 months ended June 30, 2002. Product sales for the quarter ended June 30,...

Ninth U.S. patent received.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Coley Pharmaceutical Group announced that the U.S. Patent and Trademark Office has granted U.S. Patent No. 6,406,705, providing composition claims for CpG immunostimulants in combination with adjuvants....

Virus neutralization method effective for pig-derived biomaterials.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Pig intestines used to develop human biomaterials can be cleansed of dangerous viral pathogens, researchers say. Jason Hodde and colleagues working at Cook...

Company maintains earlier profit statements.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Dutch antibody and vaccine company Crucell N.V. (CRXL) emphasized, contrary to interpretations that could be drawn from recent Dow Jones coverage, that it has not changed its profit outlook. ...

Second quarter 2002 revenues increased by 131%.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Dutch antibody and vaccine company Crucell N.V. (CRXL) announced its financial results for the second quarter 2002. During the second quarter 2002, Crucell's revenues increased by 131% over the same...

Class action lawsuit brought against CryoLife.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- The Law Firm of Cauley Geller Bowman & Coates, LLP announced that a class action lawsuit has been filed in the United States District Court for the Northern District of Georgia, Atlanta Division on...

Captisol-enabled prescription drug approved.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- CyDex, Inc., an innovator in drug delivery technologies, announced the second U.S. approval of a Captisol-Enabled product - Geodon for Injection (ziprasidone mesylate), the first atypical antipsychotic...

Preliminary fiscal 2002 performance released.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Digene Corporation (DIGE) announced preliminary financial results for fiscal year 2002 ending June 30, 2002. Digene expects fiscal year 2002 revenues in the range of $48.5 to $49 million,...

Key pharmaceutical management changes announced.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Diversa Corporation (DVSA) announced two key pharmaceutical management appointments. Gary Woodnutt, PhD, has been appointed to senior vice president, pharmaceutical R&D and Lee R. McCracken has been...

Shareholders approve actions.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Endovasc Ltd., Inc., (ENDV) announced that shareholders have approved a 1-for-40 stock split of the company's common stock and will reorganize in the State of Delaware. At the end of the business...

U.S. patent granted for small molecule program.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Esperion Therapeutics, Inc., (ESPR), a biopharmaceutical company focused on discovering and developing HDL-targeted therapies, announced that the U.S. Patent and Trademark Office has issued the first...

3-for-2 stock split announced.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Immucor, Inc., (BLUD), the global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced that its board of directors has approved a 3-for-2 stock split,...

Immunetrics receives $100,000 STTR grant.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Immunetrics, Inc., a Pittsburgh-based biomedical startup venture, said it received a $100,000 grant from the National Institutes of Health to support development of its software model of inflammation in...

Daiichi licenses CEA antibody technology.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Immunomedics, Inc., (IMMU) announced that Daiichi Pure Chemicals Co., Ltd., of Tokyo, Japan, entered into a nonexclusive license agreement under Immunomedics' carcinoembryonic antigen (CEA) patents,...

MelTec wins grant to establish collaborative proteomics research network.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- MelTec GmbH, a functional proteomics company, announced that it has been awarded a prestigious research grant, worth approximately euro 2.3 million (US $2.25 million), by the German Federal Ministry for...

Herbert Amster and Kent Talcott named to board of directors.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- NanoBio Corp., a provider of applied biologic nanotechnology, has appointed Herbert S. Amster and Kent P. Talcott to its board. Amster was the founder and chief executive officer of Irwin Magnetic...

Company raises $1.1 million through equity placement with institutional investors.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- NeoTherapeutics, Inc., (NEOT) has raised a total of $1,100,000 through the sale of 6,470,588 shares of its common stock to 4 institutional investors. The sales price of $.17 per share was at a...

NuGEN awarded SBIR grant to develop anthrax test.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- NuGEN Technologies, Inc., announced it has received a phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) to develop a rapid and sensitive assay for the...

Company names presidents of chemistry and biology.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Ontogen Corp. announced the appointment of two members to its executive management team: Richard M. Soll, PhD, joins Ontogen as vice president of chemistry, and Michael J. Newman, PhD, has been promoted...

David P. Wright named to board of directors.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- OraPharma, Inc., (OPHM) announced that David P. Wright, president and chief business officer of Guilford Pharmaceuticals, Inc., has been appointed to serve as a director on OraPharma's board. ...

PediaMed completes acquisition.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- PediaMed Pharmaceuticals, Inc., announced that it has purchased substantially all the assets of Propst Pharmaceuticals of Huntsville, Alabama. In addition to the purchase of assets, PediaMed will...

Synaptic licenses its methods for selectively antagonizing alpha-1a receptors to treat BPH.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Synaptic Pharmaceutical Corp. (SNAP), a developer of next-generation GPCR-based pharmaceuticals, and Ranbaxy Laboratories, Ltd., India's largest pharmaceutical company announced the granting of a...

Integration of Intergen and expansion of Toronto manufacturing facility complete.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Serologicals Corp. (SERO) announced successful completion of the integration of The Intergen Co. operations into Serologicals, combining the administrative, commercial, manufacturing and research and...

Company announces changes in board of directors.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- StemCells, Inc., (STEM) announced that Jean-Jacques Bienaime will join its board of directors and that Mark Levin has resigned from the board. Bienaime is the chairman, president, and CEO of...

Company appoints vice presidents of regulatory affairs and clinical development.
September 4, 2002... 2002 SEP 4 - (NewsRx.com & NewsRx.net) -- Stressgen Biotechnologies Corp. (TSSB) announced the U.S. appointments of Howard T. Holden, PhD, as an officer with the position of vice president, regulatory affairs and compliance, and Bruce M....

Company launches first product - DPN System 1.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- NanoInk, an early-stage nanotechnology company, announced the release of its initial product, DPNSystem 1. This represents the first commercial system to enable building structures with feature...

Study shows promise for identifying lead compounds.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- A recent study published in Nature Biotechnology has demonstrated a new method for identifying lead compounds for drug discovery. The method described in the study is based on technology developed...

Synthroid wins FDA approval.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories announced it received U.S. Food and Drug Administration (FDA) approval of its synthetic thyroid hormone replacement therapy, Synthroid (levothyroxine sodium tablets, USP), for...

Collaboration targets aerosol delivery of surfactants.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Discovery Laboratories, Inc., (DSCO) and Aerogen, Inc., (AEGN), announced they have entered into a collaborative relationship to evaluate the use of Discovery's proprietary humanized lung surfactant...

Agreement to focus on development of leuprolide acetate.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Durect Corporation (DRRX) and Voyager Pharmaceutical Corporation announced that the two companies have signed a development and commercialization agreement to develop Voyager's patented product, using...

New markers to be developed for use with CA125II.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Fujirebio Diagnostics, Inc., (FDI), a leading oncology diagnostics company, announced that it has acquired the rights from Pacific Northwest Research Institute (PNRI) to develop two newly discovered...

Loyola Medical Center, Medix announce laboratory connectivity project findings.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Medix Resources, Inc., (MXR), a provider of Internet-based healthcare connectivity and data integration tools, and Loyola University Medical Center, announced the initial findings of a live field test...

NeoTherapeutics issued new patent.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- NeoTherapeutics Inc., (NEOT) announced that it has been issued U.S. Patent No. 6,407,237 entitled "Novel Crystal Forms of 9-Subsituted Hypoxanthine Derivatives." This new patent provides for the...

Net loss reported at $0.32 per share.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- 3-Dimensional Pharmaceuticals, Inc., (DDDP) (3DP), a drug discovery and development company, reported its financial results for the second quarter and 6 months ended June 30, 2002. Revenue for the...

Company's revenues decrease 3%.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Abaxis, Inc., (ABAX), a medical products company manufacturing point-of-care blood analysis systems, reported financial results for its first fiscal quarter ended June 30, 2002. For the quarter,...

Second half net losses: $.009 per share.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Arena Pharmaceuticals, Inc., (ARNA) reported revenues of $5.8 million for the quarter ended June 30, 2002, a 75% increase over second quarter 2001 revenues of $3.3 million, and $10.1 million for the 6...

Mark R. Trusheim added to board of directors.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Arradial, Inc., a rapidly growing biopharmaceutical company developing novel microfluidic systems for drug discovery, announced the appointment of Mark R. Trusheim to its board of directors. ...

Company cites continued progress in R&D activities.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- AtheroGenics, Inc., (AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, reported financial results for the 3 and 6 months ended June 30, 2002, reflecting...

Plans to invalidate Genzyme patents-in-suit move forward.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Atrium Medical Corporation announced that it will continue to aggressively defend the patent infringement suit brought by Genzyme at the trial currently scheduled for November 2002, and Atrium will...

Viragen and Roslin announce resolution of litigation.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Viragen, Inc., (VRA), AviGenics, Inc., the Roslin Institute, and Dr. Helen Sang jointly announced the resolution of all lawsuits among the parties. In a public joint statement Carl Marhaver, CEO of...

FDA issues approvable letter for Vardenafil.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Bayer AG (BAY) and GlaxoSmithKline plc (GSK) announced that they have received an approvable letter from the U.S. Food and Drug Administration (FDA) for vardenafil, an oral investigational drug under...

Second quarter revenues decreased.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- BioCryst Pharmaceuticals, Inc., (BCRX) announced financial results for the second quarter ended June 30, 2002. The company reported revenues of $461,000 in the second quarter of 2002, compared...

Rolling BLA filed for Aldurazyme.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- BioMarin Pharmaceutical, Inc., (BMRN) and Genzyme General (GENZ) announced that the companies submitted the final portion of their "rolling" biologics license application (BLA) for Aldurazyme...

Record revenue, profit reported for 2Q.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- BioReliance Corporation (BREL) reported record revenue and profit for its second quarter ended June 30, 2002. Revenue increased 27% to $20.7 million from $16.3 million for the second quarter of...

Deirdre Baker named new general manager.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- BioShield Technologies, Inc., (BSTI) announced the hiring of its new general manager, Deirdre S. Baker, a 17-year business veteran, with 14 years served in various management and leadership positions...

CDP 571 didn't meet primary endpoints in study.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Biogen, Inc., (BGEN) and Celltech Group plc (CLL) announced that two phase III studies of CDP 571 did not meet the primary endpoints for patients with moderate-to-severe Crohn disease. The...

Favorable trends lead company to increase its revenue growth objectives.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Biosite Incorporated (BSTE), a leader in the drive to improve healthcare through better diagnosis, reported strong growth in sales and profits for the second quarter and 6 months ending June 30, 2002....

Sales for the second quarter decreased 14%.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Bristol-Myers Squibb Company (BMY) announced sales and earnings for the period ended June 30, 2002. Sales for the second quarter decreased 14% (13% excluding foreign exchange) to $4.1 billion from...

Net loss for quarter: $0.02 per share.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Celgene Corporation (CELG) announced that Thalomid (thalidomide) sales increased 52% for the quarter ended June 30, 2002, to $28.4 million from $18.7 million in the second quarter of 2001. Total...

Net income reported at $0.17 per share.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Cell Genesys, Inc., (CEGE) reported net income of $6.5 million or $0.17 per fully diluted share for the quarter ended June 30, 2002. This compares with a net loss of $4.7 million or $0.14 per share...

Second quarter pro forma results: $0.29 per share.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Chiron Corporation (CHIR) reported pro forma net income from continuing operations of $56 million or $0.29 per share for the second quarter of 2002, compared with $40 million, or $0.21 per share, in...

Earnings per share reported at $0.10 in 1Q of fiscal 2003.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Cholestech Corporation (CTEC) announced revenue of $11.6 million for the quarter ended June 28, 2002, as compared with revenue of $12.4 million in the first quarter of fiscal 2002. The company's...

Second quarter net loss: $0.20 per share.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Corvas International, Inc., (CVAS) reported financial results for the second quarter of 2002, which were in line with management's expectations. Second quarter operating revenues of $46,000 and...

Earnings of $0.21 per share beat consensus estimates.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- Covance, Inc., (CVD) reported earnings for its second quarter ended June 30, 2002, of $0.21/diluted share, ahead of analysts' consensus estimates of $0.20/share. "For the second consecutive...

Board of directors authorizes purchase of common stock.
September 11, 2002... 2002 SEP 11 - (NewsRx.com & NewsRx.net) -- CryoLife, Inc., (CRY), the leader in the development and commercialization of living human tissue implantable devices, and a manufacturer and distributor of stentless heart valves and surgical...